Galapagos N.V.(GLPG)Earnings, Financials & Key Ratios
GLPG•NASDAQ
$28.81
$1.9B mkt cap·5.1× P/E·Price updated May 6, 2026
AboutGalapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, small bowel CD, fistulizing CD, ankylosing spondylitis, psoriatic arthritis, and uveitis. The company's pipeline products also comprise GLPG1972 that has completed Phase 2b trial for treating osteoarthritis; Toledo molecules, including GLPG3970, GLPG4399, and GLPG4876 for inflammation; and GLPG4716 and Ziritaxestat to treat idiopathic pulmonary fibrosis. In addition, its other pipeline products include GLPG2737, a cystic fibrosis transmembrane conductance regulator that is in Phase 2 clinical trials to treat patients with autosomal dominant polycystic kidney disease; and GLPG0555, a JAK1 inhibitor, which is in Phase 1b for treatment of patients with osteoarthritis. The company has collaboration agreements with Gilead Sciences, Inc.; AbbVie S.à r.l.; and Novartis Pharma AG. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.Show more
- Revenue$1.11B+303.5%
- EBITDA$535M+474.7%
- Net Income$321M+333.2%
- EPS (Diluted)4.85+333.0%
- Gross Margin56.02%-35.9%
- EBITDA Margin48.12%+192.9%
- Operating Margin45.08%+166.0%
- Net Margin28.85%+7.4%
- ROE10.47%+302.2%
- ROIC12.54%+343.4%
- Debt/Equity0.00-47.2%
- Interest Coverage279.56+11814.7%
GLPG Key Insights
Galapagos N.V. (GLPG) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Strong 5Y sales CAGR of 18.4%
- ✓Trading at only 0.5x book value
✗Weaknesses
- ✗Negative free cash flow
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
GLPG Price & Volume
Galapagos N.V. (GLPG) stock price & volume — 10-year historical chart
Loading chart...
GLPG Growth Metrics
Galapagos N.V. (GLPG) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years39.6%
5 Years18.4%
3 Years66.43%
TTM303.48%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM333.17%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM356.6%
Return on Capital
10 Years-0.57%
5 Years0.16%
3 Years2.39%
Last Year14.22%
GLPG Recent Earnings
Galapagos N.V. (GLPG) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 7/12 qtrs (64%)
Q1 2026Latest
Feb 23, 2026EPS
$16.38
Est $1.00
+1538.0%
Revenue
$1.2B
Est $84M
+1370.9%
Q4 2025
Nov 5, 2025EPS
$3.59
Est $0.20
-1696.4%
Revenue
$83M
Est $80M
+4.0%
Q3 2025
Jul 23, 2025EPS
$1.89
Est $0.67
-182.3%
Revenue
$77M
Est $81M
-5.1%
Q2 2025
Apr 23, 2025EPS
$2.47
Est $0.23
-973.9%
Revenue
$82M
Est $78M
+5.1%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 23, 2026 | $16.38vs $1.00+1538.0% | $1.2Bvs $84M+1370.9% |
| Q4 2025 | Nov 5, 2025 | $3.59vs $0.20-1696.4% | $83Mvs $80M+4.0% |
| Q3 2025 | Jul 23, 2025 | $1.89vs $0.67-182.3% | $77Mvs $81M-5.1% |
| Q2 2025 | Apr 23, 2025 | $2.47vs $0.23-973.9% | $82Mvs $78M+5.1% |
Based on last 12 quarters of dataView full earnings history →
GLPG Peer Comparison
Galapagos N.V. (GLPG) competitors in Immunology and Inflammation Therapies — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 ARCT | 259.5M | 9.13 | -3.80 | -51.43% | -88.75% | -29.13% | 0.12 | |
 ACAD | 3.68B | 21.48 | 9.38 | 11.87% | 36.49% | 41.9% | 0.04 | |
 HALO | 7.81B | 66.35 | 25.92 | 37.55% | 22.69% | 6.49% | ||
 EXEL | 12.37B | 48.70 | 17.52 | 6.98% | 35.08% | 40.21% | 0.08 | |
 IONS | 12.7B | 76.85 | -32.29 | 33.87% | -30.87% | -58.57% | 5.35 | |
 INCY | 19.95B | 99.85 | 15.58 | 21.22% | 26.71% | 29.31% | 0.01 | |
 ABBV | 362.56B | 204.98 | 86.49 | 8.57% | 6.91% | 62.15% | ||
 LLY | 932.64B | 987.11 | 43.01 | 44.7% | 34.98% | 101.17% | 1.60 |
Compare GLPG vs Peers
Galapagos N.V. (GLPG) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
GLPG Income Statement
Galapagos N.V. (GLPG) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 127.09M | 288.84M | 834.9M | 478.05M | 484.85M | 241.25M | 239.72M | 275.65M | 1.11B |
| Revenue Growth % | -1.88% | 127.27% | 189.06% | -42.74% | 1.42% | -50.24% | -0.63% | 14.99% | 303.48% |
| Cost of Goods Sold | 218.5M | 322.88M | 420.09M | 523.67M | 1.63M | 0 | 0 | 34.86M | 489.1M |
| COGS % of Revenue | 171.93% | 111.79% | 50.32% | 109.54% | 0.34% | - | - | 12.65% | 43.98% |
| Gross Profit | -91.42M▲ 0% | -34.04M▲ 62.8% | 414.81M▲ 1318.6% | -45.61M▼ 111.0% | 483.22M▲ 1159.4% | 241.25M▼ 50.1% | 239.72M▼ 0.6% | 240.79M▲ 0.4% | 623.1M▲ 158.8% |
| Gross Margin % | -71.93% | -11.79% | 49.68% | -9.54% | 99.66% | 100% | 100% | 87.35% | 56.02% |
| Gross Profit Growth % | -808.97% | 62.76% | 1318.6% | -111% | 1159.36% | -50.07% | -0.63% | 0.44% | 158.78% |
| Operating Expenses | 216.89M | 333.64M | 46.06M | 133.02M | 648.81M | 372.31M | 327.99M | 429.12M | 328M |
| OpEx % of Revenue | 170.66% | 115.51% | 5.52% | 27.82% | 133.82% | 154.32% | 136.82% | 155.68% | 29.49% |
| Selling, General & Admin | 20.56M | 29.64M | 96.96M | 185.22M | 167.22M | 103.31M | 94.25M | 96.88M | 111.96M |
| SG&A % of Revenue | 16.18% | 10.26% | 11.61% | 38.75% | 34.49% | 42.82% | 39.32% | 35.15% | 10.07% |
| Research & Development | 218.5M | 322.88M | 420.09M | 523.67M | 491.71M | 269.8M | 241.29M | 335.46M | 459.4M |
| R&D % of Revenue | 171.93% | 111.79% | 50.32% | 109.54% | 101.42% | 111.83% | 100.65% | 121.7% | 41.31% |
| Other Operating Expenses | -22.17M | -18.87M | -470.99M | -575.87M | -10.11M | -802K | -7.56M | -3.21M | -243.36M |
| Operating Income | -89.8M▲ 0% | -44.81M▲ 50.1% | 368.75M▲ 923.0% | -178.63M▼ 148.4% | -165.6M▲ 7.3% | -131.06M▲ 20.9% | -88.26M▲ 32.7% | -188.34M▼ 113.4% | 501.39M▲ 366.2% |
| Operating Margin % | -70.66% | -15.51% | 44.17% | -37.37% | -34.15% | -54.32% | -36.82% | -68.33% | 45.08% |
| Operating Income Growth % | -681.5% | 50.1% | 922.97% | -148.44% | 7.3% | 20.86% | 32.65% | -113.38% | 366.22% |
| EBITDA | -85.52M | -39.73M | 374.24M | -170.67M | -144.29M | -65.49M | -44.62M | -142.84M | 535.17M |
| EBITDA Margin % | -67.29% | -13.75% | 44.82% | -35.7% | -29.76% | -27.15% | -18.61% | -51.82% | 48.12% |
| EBITDA Growth % | -1070.02% | 53.55% | 1042.06% | -145.61% | 15.46% | 54.61% | 31.87% | -220.12% | 474.66% |
| D&A (Non-Cash Add-back) | 4.29M | 5.08M | 5.5M | 7.96M | 21.3M | 65.57M | 43.64M | 45.5M | 33.78M |
| EBIT | -114.57M | -30.64M | 368.75M | -178.63M | -122.23M | -61.69M | 7.39M | -2.17M | 451.12M |
| Net Interest Income | 1.67M | 3.87M | 14.17M | -150.48K | -8.73M | 8.94M | 77.64M | 88.86M | 42.9M |
| Interest Income | 3.04M | 5.22M | 16.01M | 11.43M | 2.87M | 18.09M | 79.29M | 89.77M | 44.51M |
| Interest Expense | 936K | 780K | 1.84M | 11.58M | 11.59M | 9.15M | 1.65M | 911K | 1.61M |
| Other Income/Expense | -25.7M | 15.6M | -219.89M | -131.14M | 48.57M | 60.21M | 93.89M | 185.25M | -200.52M |
| Pretax Income | -115.51M▲ 0% | -29.21M▲ 74.7% | 148.85M▲ 609.6% | -309.77M▼ 308.1% | -123M▲ 60.3% | -70.85M▲ 42.4% | 5.63M▲ 107.9% | -3.08M▼ 154.8% | 300.87M▲ 9852.7% |
| Pretax Margin % | -90.89% | -10.11% | 17.83% | -64.8% | -25.37% | -29.37% | 2.35% | -1.12% | 27.05% |
| Income Tax | 198K | 50K | 165K | 1.23M | 2.42M | 572K | 9.61M | -1.8M | -18.62M |
| Effective Tax Rate % | -0.17% | -0.17% | 0.11% | -0.4% | -1.97% | -0.81% | 170.9% | 58.44% | -6.19% |
| Net Income | -115.7M▲ 0% | -29.26M▲ 74.7% | 149.84M▲ 612.1% | -305.44M▼ 303.8% | -125.42M▲ 58.9% | -217.99M▼ 73.8% | 211.7M▲ 197.1% | 74.08M▼ 65.0% | 320.9M▲ 333.2% |
| Net Margin % | -91.04% | -10.13% | 17.95% | -63.89% | -25.87% | -90.36% | 88.31% | 26.88% | 28.85% |
| Net Income Growth % | -314.22% | 74.71% | 612.13% | -303.83% | 58.94% | -73.81% | 197.11% | -65.01% | 333.17% |
| Net Income (Continuing) | -115.7M | -29.26M | 148.69M | -311M | -125.42M | -71.42M | -3.99M | -1.28M | 319.49M |
| Discontinued Operations | 0 | 0 | 1.16M | 5.57M | 0 | -146.57M | 215.69M | 75.36M | 1.4M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -2.34▲ 0% | -0.56▲ 76.1% | 2.60▲ 564.3% | -4.78▼ 283.8% | -1.91▲ 60.0% | -3.32▼ 73.8% | -0.06▲ 98.2% | 1.12▲ 1951.2% | 4.85▲ 333.0% |
| EPS Growth % | -305.26% | 76.07% | 564.29% | -283.85% | 60.04% | -73.82% | 98.18% | 1951.24% | 333.04% |
| EPS (Basic) | -2.34 | -0.56 | 2.60 | -4.78 | -1.91 | -3.32 | -0.06 | 1.12 | 4.85 |
| Diluted Shares Outstanding | 49.48M | 52.11M | 57.61M | 65.08M | 65.5M | 65.7M | 65.93M | 66.14M | 65.89M |
| Basic Shares Outstanding | 49.45M | 52.11M | 57.61M | 65.08M | 65.5M | 65.7M | 65.93M | 66.14M | 66.18M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
GLPG Balance Sheet
Galapagos N.V. (GLPG) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 1.2B | 1.33B | 5.87B | 5.37B | 4.86B | 4.24B | 3.86B | 3.34B | 3.08B |
| Cash & Short-Term Investments | 1.15B | 1.29B | 5.78B | 5.16B | 4.7B | 4.09B | 3.68B | 3.12B | 3B |
| Cash Only | 1.15B | 1.29B | 1.86B | 2.14B | 2.23B | 508.12M | 166.8M | 64.24M | 87.83M |
| Short-Term Investments | 0 | 0 | 3.92B | 3.03B | 2.47B | 3.59B | 3.52B | 3.05B | 2.91B |
| Accounts Receivable | 41.79M | 33.53M | 80.11M | 173.4M | 128.6M | 77.34M | 65.66M | 47.48M | 53.2M |
| Days Sales Outstanding | 120.02 | 42.38 | 35.02 | 132.39 | 96.81 | 117.02 | 99.97 | 62.87 | 17.46 |
| Inventory | 279K | 276K | 255K | 355K | 20.57M | 52.92M | 73.98M | 51.19M | 0 |
| Days Inventory Outstanding | 0.47 | 0.31 | 0.22 | 0.25 | 4.61K | - | - | 535.96 | - |
| Other Current Assets | 3.83M | 4.1M | 4.44M | 33.91M | 9.3M | 12.03M | 36.72M | 123.11M | 28.17M |
| Total Non-Current Assets | 88.63M | 110.64M | 202.68M | 348.38M | 331.31M | 497.5M | 495.81M | 796.27M | 326.92M |
| Property, Plant & Equipment | 16.69M | 23.14M | 66.05M | 103.38M | 137.51M | 154.25M | 126.32M | 122.9M | 0 |
| Fixed Asset Turnover | 7.61x | 12.48x | 12.64x | 4.62x | 3.53x | 1.56x | 1.90x | 2.24x | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 69.81M | 69.56M | 70.01M | 0 |
| Intangible Assets | 2.5M | 3.63M | 24.93M | 67.57M | 60.1M | 146.35M | 127.91M | 164.86M | 847.64K |
| Long-Term Investments | 1.75M | 6M | 11.28M | 8.95M | 0 | 0 | 13.57M | 253.12M | 221.13M |
| Other Non-Current Assets | 65.7M | 75.36M | 96.22M | 164.01M | 129.66M | 125.72M | 157.32M | 183.9M | 104.95M |
| Total Assets | 1.29B▲ 0% | 1.44B▲ 11.9% | 6.07B▲ 321.6% | 5.72B▼ 5.8% | 5.19B▼ 9.2% | 4.73B▼ 8.8% | 4.36B▼ 8.0% | 4.14B▼ 5.1% | 3.41B▼ 17.7% |
| Asset Turnover | 0.10x | 0.20x | 0.14x | 0.08x | 0.09x | 0.05x | 0.06x | 0.07x | 0.33x |
| Asset Growth % | 18.73% | 11.91% | 321.58% | -5.78% | -9.17% | -8.83% | -7.96% | -5.09% | -17.67% |
| Total Current Liabilities | 171.7M | 219.91M | 571.79M | 635.27M | 566.47M | 522.54M | 428.22M | 335.08M | 152.8M |
| Accounts Payable | 47.12M | 68.04M | 142.51M | 171.32M | 134.3M | 133.3M | 134.65M | 97.78M | 104.6M |
| Days Payables Outstanding | 78.72 | 76.91 | 123.82 | 119.41 | 30.09K | - | - | 1.02K | 78.06 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 122.54M | 149.8M | 414.3M | 443.16M | 419.87M | 365.63M | 256.27M | 0 | 0 |
| Other Current Liabilities | 0 | 1K | 6.2M | 12.08M | 204K | 8.51M | 32.04M | 232.72M | 45.51M |
| Current Ratio | 6.98x | 6.04x | 10.26x | 8.45x | 8.58x | 8.11x | 9.02x | 9.97x | 20.15x |
| Quick Ratio | 6.97x | 6.04x | 10.26x | 8.45x | 8.55x | 8.01x | 8.84x | 9.81x | 20.15x |
| Cash Conversion Cycle | 41.77 | -34.23 | -88.58 | 13.23 | -25.39K | - | - | -424.89 | - |
| Total Non-Current Liabilities | 102.59M | 5.34M | 2.62B | 2.41B | 1.98B | 1.69B | 1.13B | 903.7M | 17.78M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 19.56M | 23.04M | 19.66M | 14.69M | 4.94M | 8.24M | 5.18M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 20.15M | 23.61M | 20.66M | 0 |
| Other Non-Current Liabilities | 5.24M | 5.34M | 15.25M | 23.09M | 18.83M | 27.35M | 33.86M | 35.92M | 12.6M |
| Total Liabilities | 274.29M | 225.25M | 3.19B | 3.05B | 2.55B | 2.21B | 1.56B | 1.24B | 170.58M |
| Total Debt | 9K | 0 | 25.38M | 29.44M | 26.86M | 21.9M | 9.6M | 11.72M | 6.92M |
| Net Debt | -1.15B | -1.29B | -1.84B | -2.11B | -2.21B | -486.22M | -157.21M | -52.52M | -80.92M |
| Debt / Equity | 0.00x | - | 0.01x | 0.01x | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x |
| Debt / EBITDA | - | - | 0.07x | - | - | - | - | - | 0.01x |
| Net Debt / EBITDA | - | - | -4.91x | - | - | - | - | - | -0.15x |
| Interest Coverage | -122.40x | -39.28x | 199.92x | -15.42x | -10.54x | -6.74x | 4.47x | -2.39x | 279.56x |
| Total Equity | 1.01B▲ 0% | 1.21B▲ 20.0% | 2.88B▲ 136.8% | 2.67B▼ 7.1% | 2.64B▼ 1.0% | 2.53B▼ 4.4% | 2.8B▲ 10.7% | 2.9B▲ 3.6% | 3.23B▲ 11.7% |
| Equity Growth % | 33.38% | 19.99% | 136.83% | -7.14% | -1.01% | -4.44% | 10.67% | 3.63% | 11.65% |
| Book Value per Share | 20.45 | 23.30 | 49.91 | 41.04 | 40.36 | 38.45 | 42.40 | 43.80 | 49.09 |
| Total Shareholders' Equity | 1.01B | 1.21B | 2.88B | 2.67B | 2.64B | 2.53B | 2.8B | 2.9B | 3.23B |
| Common Stock | 233.41M | 236.54M | 287.28M | 291.31M | 292.07M | 293.6M | 293.94M | 293.94M | 293.81M |
| Retained Earnings | -211.44M | -297.78M | -109.22M | -334.7M | -367.2M | -496.69M | -228.27M | -134.31M | 210.49M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -3.01M | -2.29M | -5.98M | -14.1M | -11.9M | -6.45M | -7.09M | 314K | 3M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GLPG Cash Flow Statement
Galapagos N.V. (GLPG) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -147.03M | -142.47M | 3.6B | -427.34M | -503.83M | -500.54M | -405.97M | -320.03M | -189.23M |
| Operating CF Margin % | -115.69% | -49.32% | 430.82% | -89.39% | -103.91% | -207.48% | -169.35% | -116.1% | -17.01% |
| Operating CF Growth % | -161.42% | 3.1% | 2624.74% | -111.88% | -17.9% | 0.65% | 18.89% | 21.17% | 40.87% |
| Net Income | -115.7M | -29.26M | 166.42M | -305.44M | -103.23M | -217.99M | 211.7M | 74.08M | 320.9M |
| Depreciation & Amortization | 4.29M | 5.08M | 12.1M | 18.68M | 34.64M | 65.57M | 43.64M | 35.4M | 0 |
| Stock-Based Compensation | 16.54M | 26.76M | 0 | 79.96M | 70.73M | 88.51M | 56.72M | 0 | 0 |
| Deferred Taxes | 198K | 50K | 0 | 2.12M | 2.42M | 2.84M | 11.69M | -1.71M | 0 |
| Other Non-Cash Items | 26.22M | -11.71M | 265.57M | 131.22M | -78M | -60M | -37.28M | -362.76M | 375.54M |
| Working Capital Changes | -78.56M | -133.39M | 3.15B | -353.88M | -430.38M | -379.47M | -692.43M | -65.04M | -885.68M |
| Change in Receivables | -27.66M | -76K | -75.28M | -177.16M | 79.86M | 68.98M | -39.11M | -31.05M | 0 |
| Change in Inventory | 22K | 3K | 22.38K | -100K | -21.17M | -34.59M | -24.08M | 23.04M | 0 |
| Change in Payables | 14.77M | 20M | 89.47M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -549K | -15.91M | -4.22B | 757.29M | 541.24M | -1.25B | 71.19M | 220.6M | 219.35M |
| Capital Expenditures | -7.44M | -13.72M | -51.13M | -42.52M | -54.2M | -27.39M | -18.71M | -16.72M | 0 |
| CapEx % of Revenue | 5.85% | 4.75% | 6.12% | 8.89% | 11.18% | 11.35% | 7.8% | 6.07% | 1.18% |
| Acquisitions | 7K | 3.33M | 0 | 0 | 28.7M | -115.27M | -7M | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | 6.52M | -3.32M | 0 | -45.24M | -3.66M | -15.82M | 16.62M | 237.32M | 219.35M |
| Cash from Financing | 353.36M | 287.88M | 1.5B | 22.04M | -3.88M | -1.49M | -5M | -4.92M | -3.14M |
| Debt Issued (Net) | -65K | -5K | -5.7M | -6.25M | -7.19M | -8.18M | -6.77M | -4.92M | 0 |
| Equity Issued (Net) | 363.92M | 296.19M | 1.5B | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -10.5M | -8.31M | 0 | 28.29M | 3.31M | 6.7M | 1.77M | 0 | -3.14M |
| Net Change in Cash | 177.97M▲ 0% | 139.59M▼ 21.6% | 382.13M▲ 173.8% | 281.45M▼ 26.3% | 90.3M▼ 67.9% | -1.73B▼ 2010.6% | -341.31M▲ 80.2% | -102.57M▲ 69.9% | -5.06M▲ 95.1% |
| Free Cash Flow | -154.47M▲ 0% | -156.18M▼ 1.1% | 3.57B▲ 2387.0% | -518.65M▼ 114.5% | -561.71M▼ 8.3% | -537.49M▲ 4.3% | -425.24M▲ 20.9% | -402.14M▲ 5.4% | -202.4M▲ 49.7% |
| FCF Margin % | -121.54% | -54.07% | 427.82% | -108.49% | -115.85% | -222.8% | -177.39% | -145.89% | -18.2% |
| FCF Growth % | -165.84% | -1.11% | 2386.96% | -114.52% | -8.3% | 4.31% | 20.88% | 5.43% | 49.67% |
| FCF per Share | -3.12 | -3.00 | 62.00 | -7.97 | -8.58 | -8.18 | -6.45 | -6.08 | -3.07 |
| FCF Conversion (FCF/Net Income) | 1.27x | 4.87x | 24.00x | 1.40x | 4.02x | 2.30x | -1.92x | -4.32x | -0.59x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 689K | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GLPG Key Ratios
Galapagos N.V. (GLPG) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 9.61% | -13.07% | -2.63% | 7.33% | -11.01% | -4.72% | -8.43% | 7.96% | 2.6% | 10.47% |
| Return on Invested Capital (ROIC) | - | - | - | 57.44% | -16.7% | -24.8% | -7.94% | -2.83% | -5.15% | 12.54% |
| Gross Margin | -7.76% | -71.93% | -11.79% | 49.68% | -9.54% | 99.66% | 100% | 100% | 87.35% | 56.02% |
| Net Margin | 41.7% | -91.04% | -10.13% | 17.95% | -63.89% | -25.87% | -90.36% | 88.31% | 26.88% | 28.85% |
| Debt / Equity | 0.00x | 0.00x | - | 0.01x | 0.01x | 0.01x | 0.01x | 0.00x | 0.00x | 0.00x |
| Interest Coverage | -244.47x | -122.40x | -39.28x | 199.92x | -15.42x | -10.54x | -6.74x | 4.47x | -2.39x | 279.56x |
| FCF Conversion | 4.43x | 1.27x | 4.87x | 24.00x | 1.40x | 4.02x | 2.30x | -1.92x | -4.32x | -0.59x |
| Revenue Growth | 227.37% | -1.88% | 127.27% | 189.06% | -42.74% | 1.42% | -50.24% | -0.63% | 14.99% | 303.48% |
GLPG Frequently Asked Questions
Galapagos N.V. (GLPG) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Galapagos N.V. (GLPG) reported $1.11B in revenue for fiscal year 2025. This represents a 14201% increase from $7.8M in 2004.
Galapagos N.V. (GLPG) grew revenue by 303.5% over the past year. This is strong growth.
Yes, Galapagos N.V. (GLPG) is profitable, generating $320.9M in net income for fiscal year 2025 (28.9% net margin).
Dividend & Returns
Galapagos N.V. (GLPG) has a return on equity (ROE) of 10.5%. This is reasonable for most industries.
Galapagos N.V. (GLPG) had negative free cash flow of $265.5M in fiscal year 2025, likely due to heavy capital investments.
Explore More GLPG
Galapagos N.V. (GLPG) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates